companies

Sidekick Health

Founded 2013
Employees 130+
Primary contact
Vallakor 4
203 Kopavogur
Iceland
Links
https://sidekickhealth.com/
Diseases & Conditions
Sections
Technologies
Sidekick Health is a digital therapeutics company that helps people prevent and manage chronic diseases. The company's approach combines behavioral economics, gamification, and artificial intelligence for an engaging experience that removes barriers to health behavior change and expands the possibilities of well-being. Together with its pharmaceutical and insurance partners, Sidekick designs personalized lifestyle change programs that improve health outcomes and treatment adherence, create connections between patients and clinicians, and deliver data insights into some of the world's most pressing health challenges. In addition to its headquarters in Iceland, the company also has offices in Berlin, Boston, and Stockholm.
Select partners: Anthem, Pfizer, Bayer, Ypsomed.
Founded 2013
Employees 130+
Primary contact
Vallakor 4
203 Kopavogur
Iceland
Links
https://sidekickhealth.com/
Diseases & Conditions
Sections
Technologies

Funding 💰

Total $85.9M
Last round 🔗 $55M
Series B
May 5, 2022.
Select investors Novator, Wellington Partners, Asabys Partners, Frumtak Ventures, Technology Development Fund

Key people 🧑‍🤝‍🧑

Highlights ⭐

  • Growing market: The global digital therapeutics market is projected to reach $13.1 billion by 2026, growing at a CAGR of 31.4% between 2022 and 2026. 🔗
  • Multiple therapeutic areas: Sidekick programs provide support to patients suffering from chronic illnesses ranging from diabetes to ulcerative colitis. They can be layered and fitted-for-purpose to work both as a prevention tool, as well as provide support and empower patients.
  • Clinically-validated: Sidekick's clinically-validated digital platform has a demonstrated history in helping people modify their behavior, increase treatment adherence and better manage chronic illnesses and symptoms. It has been rated in the top 0.1% in quality by the industry's leading rating company Orcha and is proud of successful customer launches across multiple therapeutic areas - ranging from type 2 diabetes, ulcerative colitis, and smoking cessation. 🔗
  • Proven track record: Sidekick users are three times more likely to reach their 5% weight-loss goals. Also, Sidekick programs deliver 30% higher adherence compared to standard care, while delivering industry-leading retention - 80% after four months and 75% after six months.
  • Media love: Sidekick Health has been featured in a number of prominent publications, including The Financial Times, The Wall Street Journal, Bloomberg, TechCrunch, Business Insider, Sifted, Silicon Republic, Tech.eu, and more. 🔗

Video ▶️

Awards & Recognitions 🏆

  • 2020 eHealth Award Winner 🔗
  • 2019 Winter Summit in Sunnyvale: First prize
  • 2019 EIT Digital Challenge: One of 10 winners
  • 2019 Norrsken Award: One of the best impact startups in the Nordics 🔗
  • 2018 Silicon Republic: 20 of Europe's top health and medtech start-ups 🔗
  • 2018 AXA Health Tech & You Awards finalist 🔗

Quotes 💬

“
It has been impressive to follow the rapid growth of the company from the close of its A round 18 months ago. The company may have begun in the Nordics, but I am proud to say that Sidekick is now a globally-recognized digital therapeutics player. Novator Ventures recognizes the immense opportunities presented by third generation therapeutics and Sidekick's ability to scale and operate at the global level. We look forward to working closely with the Sidekick team to transform how healthcare is delivered.
— Birgir Mar Ragnarsson, Novator Ventures general partner and founder 🔗
“
At Wellington, we are all about improving healthcare for all stakeholders, patients, practitioners, and payors alike. Sidekick's team has done a remarkable job of creating a product platform with the potential to achieve this aim on a global scale. We are very excited to support the company with their plans for significant growth.
— Dr. Regina Hodits, managing partner at Wellington 🔗
“
We are impressed by the way this team has been able to put together a technology platform delivering evidence-based therapeutic programs, that are effective, adaptive but also valuable for their commercial partners. Sidekick clearly ticks all the boxes of what we are looking for at Asabys.
— Josep LI. Sanfeliu, managing partner and co-founder of Asabys 🔗
Last update: January 13, 2023